BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 10785491)

  • 61. Vaginal semiradical hysterectomy: a new operative procedure for microinvasive carcinoma of the cervix.
    Kudo R; Ito E; Kusanagi T; Hashimoto M
    Obstet Gynecol; 1984 Dec; 64(6):810-5. PubMed ID: 6504424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of carcinoma in situ of the cervix experience at the Faculty of Medicine, University of São Paulo.
    Souen JS; Carvalho JP; Filassi JR; Marques JA; Ades A; Pinotti JA
    Rev Paul Med; 1992; 110(6):276-9. PubMed ID: 1341025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adenocarcinoma in situ coexisting with carcinoma in situ of the cervix during pregnancy.
    Nagaishi M; Fujiwaki R; Hata K; Makihara K; Yamane Y; Miyazaki K
    Arch Gynecol Obstet; 2004 Sep; 270(2):116-8. PubMed ID: 15449069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Laparoscopic assisted parametrectomy/upper vaginectomy (LPUV)-technique, applications and results.
    Fleisch MC; Hatch KD
    Gynecol Oncol; 2005 Sep; 98(3):420-6. PubMed ID: 16005499
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vaginal cancer after hysterectomy for benign disease: value of cytologic screening.
    Bell J; Sevin BU; Averette H; Nadji M
    Obstet Gynecol; 1984 Nov; 64(5):699-702. PubMed ID: 6493662
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An investigation of the mechanisms underlying the disparity between rate of residual endocervical adenocarcinoma in situ (AIS) in hysterectomy specimens and clinical failure rate following conservatively treated AIS.
    Goldstein NS
    Am J Clin Pathol; 2004 Oct; 122(4):540-5. PubMed ID: 15487451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carcinoma in situ of the cervix uteri.
    Selim MA; So-Bosita JL; Neuman MR
    Surg Gynecol Obstet; 1974 Nov; 139(5):697-700. PubMed ID: 4428326
    [No Abstract]   [Full Text] [Related]  

  • 69. The suitable treatment for adenocarcinoma in situ of uterine cervix: a report of four cases.
    Liu YC; Chen RJ; Chang DY; Huang SC; Chow SN
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Oct; 58(4):294-8. PubMed ID: 8994337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of cervical carcinoma in situ in HIV positive women.
    Williams FS; Roure RM; Till M; Vogler M; Del Priore G
    Int J Gynaecol Obstet; 2000 Nov; 71(2):135-9. PubMed ID: 11064010
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cold knife versus laser cone biopsy for adenocarcinoma in situ of the cervix--a comparison of management and outcome.
    Dalrymple C; Valmadre S; Cook A; Atkinson K; Carter J; Houghton CR; Russell P
    Int J Gynecol Cancer; 2008; 18(1):116-20. PubMed ID: 17506846
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Adenocarcinoma of the endocervix. Clinical cases].
    Zarcone R; Tartaglia E; Cardone G; Voto RI
    Minerva Ginecol; 1994; 46(1-2):45-8. PubMed ID: 8177462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases.
    Andersen ES; Arffmann E
    Gynecol Oncol; 1989 Oct; 35(1):1-7. PubMed ID: 2792895
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Stage IA1 squamous cell carcinoma of the uterine cervix: a report of 30 cases].
    Sun L; Zhang WH; Li SM; Wu LY; Bai P; Zhang X; Li L
    Ai Zheng; 2004 Feb; 23(2):204-6. PubMed ID: 14960246
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy.
    Boren TP; Carrick K; Kehoe SM; Lea J; Miller DS; Richardson DL
    Gynecol Oncol; 2012 Mar; 124(3):508-11. PubMed ID: 22108254
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
    Lee KR; Manna EA; Jones MA
    Acta Cytol; 1991; 35(1):117-26. PubMed ID: 1994620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of carcinoma in situ: evaluation of 1609 cases.
    Burghardt E; Holzer E
    Obstet Gynecol; 1980 May; 55(5):539-45. PubMed ID: 7366911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases.
    Qizilbash AH
    Am J Clin Pathol; 1975 Aug; 64(2):155-70. PubMed ID: 1155380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases.
    Gilks CB; Clement PB
    Mod Pathol; 1992 Jul; 5(4):426-31. PubMed ID: 1495949
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix.
    Shipman SD; Bristow RE
    Curr Opin Oncol; 2001 Sep; 13(5):394-8. PubMed ID: 11555719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.